U.S. Transportation Stock News

Walker & Dunlop (WD) has had a rough stretch recently, with the stock down about 21% over the past month and nearly 40% over the past year, raising questions about whether sentiment has overshot fundamentals. See our latest analysis for Walker & Dunlop. The latest slide, including a roughly 21% 30 day share price return and a 39.8% one year total shareholder return decline, suggests momentum is clearly fading as investors reassess commercial real estate risks and near term earnings power. If...

In late November 2025, Restaurant Brands International reported third-quarter results that topped analysts’ expectations, highlighted strong performances at Tim Hortons and its International segment, and continued progress in the Burger King U.S. turnaround, while a 3G Capital affiliate moved ahead with a secondary sale of up to 17.63 million shares. The company also outlined an accelerated global expansion plan, including a China refranchising deal and long-term unit growth targets into...

Alnylam Pharmaceuticals recently reshaped its Board of Directors, with long-serving members Mike Bonney and Carolyn Bertozzi, Ph.D., stepping down and industry veteran Stuart Arbuckle set to join as an independent director in early 2026. The leadership shift, combined with CEO Yvonne Greenstreet’s exercise of US$1.72 million in stock options, highlights both governance evolution and continued executive alignment with the company’s RNAi-focused trajectory. We’ll now explore how Arbuckle’s...

Bunge Global (BG) has quietly pulled ahead of the broader market this year, with the stock up about 21% year to date and 11% over the past 3 months despite recent weakness. See our latest analysis for Bunge Global. The latest pullback, including a 1 day share price return of minus 0.81 percent, looks more like a breather within a solid year of gains, supported by strong revenue and earnings growth and a five year total shareholder return of 62.28 percent. If Bunge’s move has you rethinking...

Main Street Capital Corporation recently completed a follow-on investment, providing an additional US$20.0 million first lien, senior secured term debt to portfolio company Chamberlin Holding LLC to support its acquisition of a commercial roofing contractor in the Southeastern United States. This additional capital deepens Main Street Capital’s multi-year relationship with Chamberlin and backs an expansion of the roofing contractor’s geographic footprint beyond its Southwest base. We’ll now...

Korn Ferry (KFY) shares have lagged the broader market over the past 3 months, even as the company continues to post steady revenue and earnings growth. This invites a closer look at its valuation. See our latest analysis for Korn Ferry. At around $66.07 per share, Korn Ferry’s 1 year total shareholder return of negative 5.25 percent contrasts with a robust 3 year total shareholder return of 37.61 percent. This suggests that longer term momentum remains intact even as near term sentiment...

Alexandria Real Estate Equities, Inc. previously cut its quarterly dividend for the fourth quarter of 2025 to US$0.72 per share, a 45% reduction from the prior quarter, payable on January 15, 2026 to shareholders of record on December 31, 2025, alongside weaker guidance and an impairment charge tied to its Long Island City property. These actions, combined with multiple securities class action filings alleging misleading disclosures about leasing, occupancy and Long Island City asset values,...

EVERTEC (EVTC) just locked in a new 150 million dollar term loan and immediately used it to pay down its revolving credit line, a balance sheet shuffle the market has welcomed. See our latest analysis for EVERTEC. The move comes after a choppy stretch, with a roughly 3.7% 1 month share price return but a weaker 1 year total shareholder return near 16% in the red, hinting that short term momentum is stabilising while longer term sentiment is still rebuilding. If this kind of balance sheet...

On December 4, 2025, Nutex Health’s board extended its previously authorized US$25,000,000 common stock repurchase program through March 31, 2026, to be executed under Rule 10b-18 and a Rule 10b5-1 trading plan. The extension underscores management’s focus on offsetting dilution from stock compensation tied to new and ramping hospitals while signaling confidence in the company’s capital allocation approach. Next, we’ll assess how extending the US$25,000,000 buyback program may influence...

Collegium Pharmaceutical (COLL) has jumped onto investors radars after a streak of earnings beats and a top research rating, with that momentum helping push the stock to a fresh 52 week high. See our latest analysis for Collegium Pharmaceutical. That surge to around $47.91 has come on the back of a powerful 33.6 percent 1 month share price return and a 67.3 percent year to date share price return, with the 5 year total shareholder return of 156.8 percent showing momentum has been building...

Bath & Body Works’ 14th Annual Candle Day event ran from December 4–7, 2025, offering its three-wick candles at about US$10, the lowest price of the year across more than 180 scents, including limited-edition and new fragrances, both online and in stores. This concentrated promotional push, featuring exclusive drops and a wide assortment of seasonal favorites, highlights how Bath & Body Works uses event-based discounting to deepen customer engagement and boost holiday-period sales. We’ll now...

Ocular Therapeutix (OCUL) has quietly put up an interesting run lately, with the stock gaining around 44% year to date and roughly 16% over the past month, drawing fresh attention. See our latest analysis for Ocular Therapeutix. That move sits against a choppy backdrop, with the latest share price at $12.58 and a strong year to date share price return, but a more mixed multi year total shareholder return profile. This suggests sentiment has improved even as risk remains firmly on the...

Earlier this month, Morgan Stanley shifted its view on 10x Genomics by downgrading the stock’s rating while maintaining coverage with a more conservative stance. This change, set against generally supportive opinions from other analysts, highlights growing differences over how to value 10x Genomics amid current conditions. We’ll now explore how Morgan Stanley’s more cautious rating, alongside a still-supportive analyst consensus, may influence 10x Genomics’ investment narrative. The end of...

Columbia Sportswear (COLM) just dropped its Star Wars inspired Endor Collection, a 20 piece collaboration that leans on fan nostalgia and premium pricing, giving investors a fresh lens on the brand. See our latest analysis for Columbia Sportswear. For investors, this launch lands at an interesting moment, with the latest share price at $55.11 and a 30 day share price return of 5.27% offering a modest bounce against a much weaker year to date share price performance and double digit negative...

TriMas (TRS) just brought back a familiar face, naming longtime finance leader Paul Swart as its new Chief Financial Officer and principal accounting officer, a move that could subtly reshape how investors view the stock. See our latest analysis for TriMas. The timing is interesting, coming after a bumpy few months in which TriMas has seen a 40.44% year to date share price return but a weaker 90 day share price return of minus 13.56%, while its 1 year total shareholder return of 30.19%...

Recently, SolarEdge Technologies reported the successful installation of its CSS-OD storage system in Germany, supported by over 150 orders totaling 15 MWh, while investors reacted to the planned expiration of U.S. residential clean energy tax credits at the end of 2025 under the One Big Beautiful Bill Act. This combination highlights how policy uncertainty in SolarEdge’s largest market contrasts with early traction for its commercial and industrial storage solutions in Europe. Next, we’ll...

MKS Inc. recently reported third-quarter 2025 results that surpassed consensus expectations for both adjusted earnings and revenue, with management issuing upbeat fourth-quarter guidance and analysts revising estimates higher. At the same time, MKS earned a place on Newsweek and Statista’s 2026 list of America’s Most Responsible Companies for the third consecutive year, reinforcing its corporate responsibility credentials alongside its operational performance. We’ll now examine how MKS’s...

Criteo (CRTO) just cleared a high bar with third quarter 2025 results coming in well ahead of expectations, a meaningful outcome for a stock that has struggled this year. See our latest analysis for Criteo. Even with the post earnings bounce, reflected in a 1 day share price return of 7.25 percent and 7 day share price return of 5.63 percent, Criteo is still working against a weak backdrop. The year to date share price return is negative 46.61 percent and the 1 year total shareholder return...

Graco (GGG) just doubled down on shareholder returns, rolling out authorization to repurchase up to 15 million shares alongside a 7% hike to its quarterly dividend, which signals management confidence. See our latest analysis for Graco. Those capital return moves land just as Graco’s share price, recently at $83.47, has cooled slightly with a negative 90 day share price return, even though the three year total shareholder return remains solidly positive. This suggests longer term momentum is...

Crane (CR) has quietly put up a strong run this year, and its latest trading action is prompting a closer look. The stock’s gains sit alongside solid revenue and earnings growth. See our latest analysis for Crane. At around $187.79 a share, Crane’s strong year to date share price return of roughly 24 percent caps a solid run that mirrors its improving fundamentals, while the three year total shareholder return above 190 percent shows sustained momentum rather than a one off spike. If Crane’s...

Recent Share Performance and Context Atmus Filtration Technologies (ATMU) has been quietly grinding higher, with the stock up about 13% over the past month and 34% year to date, outpacing many industrial peers. See our latest analysis for Atmus Filtration Technologies. With the share price now at $52.25 and a 34.22% year to date share price return, Atmus is showing firm, sustained momentum as investors respond to its earnings growth profile and cash generation. If this kind of steady...

Packaging Corporation of America (PKG) just delivered a one two punch to investors: a softer industry demand outlook for boxes and a plan to permanently shut key operations at its Wallula mill. See our latest analysis for Packaging Corporation of America. Those demand worries and the Wallula restructuring help explain why the share price return is down around 10 percent over the past quarter, even though the five year total shareholder return is still strongly positive. This suggests long...

Earlier this week, DoubleVerify announced it had appointed Stuart Flint, a former senior executive at TikTok, Verizon Media, Yahoo, AOL, and Microsoft Advertising, as Managing Director for EMEA to lead regional operations and advance its go-to-market strategy. The hire signals a push to deepen DoubleVerify’s presence across Europe, the Middle East, and Africa by leveraging Flint’s experience scaling commercial teams and forging partnerships in digital advertising. We’ll now examine how...

Wondering if Peloton Interactive is finally a bargain or still a value trap at current levels? You are not alone in trying to make sense of where this stock really belongs. After years of steep losses, including a 94.5% slide over 5 years and a 35.9% drop in the last year alone, the recent 5.4% 7 day and 10.0% 30 day moves show investors are still wrestling with what Peloton is worth. Recent headlines have focused on Peloton's ongoing turnaround efforts, including cost cutting, product...